Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Sell
46
CMCSA Quote, Financials, Valuation and Earnings
Last price:
$34.3900
Seasonality move
:
7.07%
Day range:
$34.0700 - $34.6050
52-week range:
$31.4400 - $45.3100
Dividend yield:
3.65%
P/E ratio:
8.47x
P/S ratio:
1.08x
P/B ratio:
1.49x
Volume:
16.1M
Avg. volume:
26.8M
1-year change:
-10.39%
Market cap:
$128.8B
Revenue:
$123.7B
EPS (TTM):
$4.07
Analysts' Opinion
-
Consensus RatingComcast has received a consensus rating of Hold. The company's average rating is a Hold based on 10 Buy ratings, 14 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $40.4954, Comcast has an estimated upside of 17.41% from its current price of $34.4900.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $30.0000 representing 100% downside risk from its current price of $34.4900.
Fair Value
-
According to the consensus of 25 analysts, Comcast has 17.41% upside to fair value with a price target of $40.4954 per share.
CMCSA vs. S&P 500
-
Over the past 5 trading days, Comcast has overperformed the S&P 500 by 1.57% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Comcast does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Comcast revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Comcast reported revenues of $29.9B.
Earnings Growth
-
Comcast earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Comcast reported earnings per share of $0.89.
Enterprise value:
220B
EV / Invested capital:
1.18x
Price / LTM sales:
1.08x
EV / EBIT:
9.89x
EV / Revenue:
1.78x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
16.39x
Price / Operating cash flow:
9.91x
Enterprise value / EBITDA:
5.89x
Gross Profit (TTM):
$86.9B
Return On Assets:
5.91%
Net Income Margin (TTM):
12.72%
Return On Equity:
18.38%
Return On Invested Capital:
8.52%
Operating Margin:
18.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $120.1B | $121.9B | $123.6B | $30.1B | $29.9B | |
| Gross Profit | $83.5B | $85.4B | $86.9B | $21.2B | $21.5B | |
| Operating Income | $22.7B | $23.5B | $23.1B | $5.8B | $5.7B | |
| EBITDA | $27.7B | $38.5B | $37.3B | $9.7B | $9.4B | |
| Diluted EPS | $1.32 | $3.78 | $4.07 | $0.97 | $0.89 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.4B | $25.4B | $22.4B | $24B | $27.3B | |
| Total Assets | $278.5B | $274.1B | $259.4B | $263.6B | $267.8B | |
| Current Liabilities | $30.8B | $29.7B | $32.4B | $40.3B | $42.3B | |
| Total Liabilities | $183.9B | $177.6B | $176B | $180.3B | $180.5B | |
| Total Equity | $94.6B | $96.5B | $83.5B | $83.3B | $87.3B | |
| Total Debt | $108.9B | $99.7B | $100.7B | $96.6B | $99.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.4B | $29.1B | $28.1B | $7.8B | $8.3B | |
| Cash From Investing | -$14.9B | -$7.3B | -$15.1B | -$3.5B | -$3B | |
| Cash From Financing | -$14.8B | -$20.8B | -$10.9B | -$4B | -$4.1B | |
| Free Cash Flow | $11.7B | $13.7B | $13.4B | $4.5B | $5.4B | |
CMCSA
Sector
Market Cap
$128.8B
$80.9M
Price % of 52-Week High
76.12%
64%
Dividend Yield
3.65%
0%
Shareholder Yield
10.13%
3.14%
1-Year Price Total Return
-10.39%
-17.26%
Beta (5-Year)
0.969
0.596
Dividend yield:
3.65%
Annualized payout:
$1.22
Payout ratio:
30.84%
Growth streak:
5 years
Technicals
8-day SMA
Buy
Level
$34.1288
200-day SMA
Sell
Level
$38.5487
Bollinger Bands (100)
Sell
Level
34.2153 - 37.9553
Chaikin Money Flow
Buy
Level
127.3M
20-day SMA
Buy
Level
$34.0010
Relative Strength Index (RSI14)
Buy
Level
50.0528
ADX Line
Sell
Level
30.0585
Williams %R
Sell
Level
-15.0418
50-day SMA
Sell
Level
$35.1890
MACD (12, 26)
Buy
Level
2.4180
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
117.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4635)
Sell
CA Score
(Annual)
Level (-0.7361)
Buy
Beneish M-Score
(Annual)
Level (-2.7028)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.8792)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 64 million US homes and businesses, or nearly half of the country. About 50% of the locations in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC network, the Peacock streaming platform, several local NBC affiliates, Universal Studios, and several theme parks. The firm plans to spin off most of its cable networks later in 2025. Finally, Sky, acquired in 2018, is a large television provider in the UK and Italy, and it also has a presence in Germany and Austria.
Stock Forecast FAQ
In the current month, CMCSA has received 10 Buy ratings 14 Hold ratings, and 1 Sell ratings. The CMCSA average analyst price target in the past 3 months is $40.4954.
-
Where Will Comcast Stock Be In 1 Year?
According to analysts, the consensus estimate is that Comcast share price will rise to $40.4954 per share over the next 12 months.
-
What Do Analysts Say About Comcast?
Analysts are divided on their view about Comcast share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Comcast is a Sell and believe this share price will drop from its current level to $30.0000.
-
What Is Comcast's Price Target?
The price target for Comcast over the next 1-year time period is forecast to be $40.4954 according to 25 Wall Street analysts, 10 of them rate the stock a Buy, 1 rates the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is CMCSA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Comcast is a Hold. 14 of 25 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CMCSA?
You can purchase shares of Comcast via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Comcast shares.
-
What Is The Comcast Share Price Today?
Comcast was last trading at $34.3900 per share. This represents the most recent stock quote for Comcast. Yesterday, Comcast closed at $34.4900 per share.
-
How To Buy Comcast Stock Online?
In order to purchase Comcast stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 19.21% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is up 0.14% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 19.76% over the past day.
